Computer-aided analysis and design of phosphonic and phosphinic enzyme inhibitors as potential drugs and agrochemicals

被引:76
作者
Berlicki, L [1 ]
Kafarski, P [1 ]
机构
[1] Wroclaw Univ Techol, Fac Chem, Dept Bioorgan Chem, PL-50370 Wroclaw, Poland
关键词
D O I
10.2174/138527205774913088
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A structure-based approach to design potent and selective inhibitors is an important component of the modern drug development process. As the altered activity of certain enzymes is associated with variety of pathologies, the design and synthesis of inhibitors for enzymes playing the key role in pathogenesis may result in potential therapeutic agents. Nowadays, the development of new inhibitors is often based on computer assisted design process. Although three-dimensional structure of the enzyme and mechanism of enzymatic reaction are most important for accurate design, the mode of action of already known lead compounds as well as their characteristic structural features also have to be considered. This review summarises the current progress in computer-aided design of phosphonic and phosphinic acids and their short peptides as inhibitors of chosen enzymes of medical and agrochemical importance. Despite the mechanism of inhibitory activity two approaches for their design are presented. First one relies on the use of the crystal structure of enzymes as well as enzymes complexed with some ligands for structure-based search for novel inhibitory structures. Second enables prediction of activity of new enzyme groups of inhibitors based on the building-up relation of observed activity to specific structural features of sets of compounds of known biological activity.
引用
收藏
页码:1829 / 1850
页数:22
相关论文
共 170 条
  • [51] Effects of bisphosphonates on the growth of Entamoeba histolytica and Plasmodium species in vitro and in vivo
    Ghosh, S
    Chan, JMW
    Lea, CR
    Meints, GA
    Lewis, JC
    Tovian, ZS
    Flessner, RM
    Loftus, TC
    Bruchhaus, I
    Kendrick, H
    Croft, SL
    Kemp, RG
    Kobayashi, S
    Nozaki, T
    Oldfield, E
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (01) : 175 - 187
  • [52] Goodwill KE, 2001, DRUG DISCOV TODAY, V6, pS113
  • [53] Quantitative structure-activity relations for γδ T cell activation by phosphoantigens
    Gossman, W
    Oldfield, E
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (22) : 4868 - 4874
  • [54] Structure of astacin with a transition-state analogue inhibitor
    Grams, F
    Dive, V
    Yiotakis, A
    Yiallouros, I
    Vassiliou, S
    Zwilling, R
    Bode, W
    Stocker, W
    [J]. NATURE STRUCTURAL BIOLOGY, 1996, 3 (08): : 671 - 675
  • [55] Nonpeptide inhibitors of cathepsin G:: Optimization of a novel β-ketophosphonic acid lead by structure-based drug design
    Greco, MN
    Hawkins, MJ
    Powell, ET
    Almond, HR
    Corcoran, TW
    de Garavilla, L
    Kauffman, JA
    Recacha, R
    Chattopadhyay, D
    Andrade-Gordon, P
    Maryanoff, BE
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (15) : 3810 - 3811
  • [56] Computer-aided design and activity prediction of leucine aminopeptidase inhibitors
    Grembecka, J
    Sokalski, WA
    Kafarski, P
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2000, 14 (06) : 531 - 544
  • [57] The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity
    Grembecka, J
    Mucha, A
    Cierpicki, T
    Kafarski, P
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (13) : 2641 - 2655
  • [58] Grembecka J., 2001, Mini-Reviews in Medicinal Chemistry, V1, P133, DOI 10.2174/1389557013406990
  • [59] Quantum chemical analysis of the interactions of transition state analogs with leucine aminopeptidase
    Grembecka, J
    Sokalski, WA
    Kafarski, P
    [J]. INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY, 2001, 84 (02) : 302 - 310
  • [60] Non-empirical analysis of the nature of the inhibitor-active-site interactions in leucine aminopeptidase
    Grembecka, J
    Kedzierski, P
    Sokalski, WA
    [J]. CHEMICAL PHYSICS LETTERS, 1999, 313 (1-2) : 385 - 392